Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow transplantation for leukemia.

E D Thomas

    Journal of Clinical Immunology
    |July 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Marrow transplantation is an accepted procedure for leukemia, offering a potential cure where chemotherapy fails. This treatment provides longer remissions and survival for acute leukemia patients, with ongoing research promising further improvements.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.

    Transplantation·1992
    Same author

    Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.

    Genomics·1992
    Same author

    Bone marrow transplantation: past experiences and future prospects.

    Seminars in oncology·1992
    Same author

    Donor alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission.

    European journal of haematology·1992
    Same author

    Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

    Bone marrow transplantation·1992
    Same author

    Acceptance of the George M. Kober Medal.

    Transactions of the Association of American Physicians·1992
    Same journal

    Facial Dysmorphism and Severe Vascular Phenotype in TRNT1 Deficiency with Concomitant Antithrombin III Deficiency.

    Journal of clinical immunology·2026
    Same journal

    Intersection Between Systemic Autoimmune Diseases, Primary Immunodeficiency and Cancer: a Field in its Infancy.

    Journal of clinical immunology·2026
    Same journal

    Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report.

    Journal of clinical immunology·2026
    Same journal

    Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center.

    Journal of clinical immunology·2026
    Same journal

    Correction to: Whole Genome Sequencing in 25 Families with Suspected Inborn Errors of Immunity: Diagnostic Yield and Clinical Relevance of Genome-wide Analysis.

    Journal of clinical immunology·2026
    Same journal

    Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation.

    Journal of clinical immunology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Marrow transplantation is an established clinical procedure for specific conditions like leukemia, severe combined immunologic deficiency, and severe aplastic anemia.
    • For relapsed acute leukemia patients, marrow grafting from an identical twin or HLA-identical sibling offers comparable or superior remission durations to chemotherapy.

    Purpose of the Study:

    • To evaluate the efficacy of marrow transplantation as a curative option for acute leukemia.
    • To compare the outcomes of marrow transplantation with conventional chemotherapy in patients with acute myeloid leukemia (ANL) in first remission.

    Main Methods:

    • Analysis of remission durations and survival rates in patients undergoing marrow transplantation.
    • Comparison of marrow transplantation outcomes against historical data from combination chemotherapy treatments.

    Related Experiment Videos

    Main Results:

    • Marrow transplantation provides a potential cure for a significant fraction of relapsed acute leukemia patients.
    • For ANL patients in first remission, marrow transplantation yields substantially longer median survivals than chemotherapy.
    • Over 50% of ANL patients in first remission may be cured with marrow transplantation, though longer follow-up is needed.

    Conclusions:

    • Marrow transplantation is a viable and potentially curative treatment for selected leukemia patients, particularly those who have relapsed or are in first remission.
    • Ongoing research into new modalities like interferon and monoclonal antibodies is expected to enhance marrow transplantation outcomes.